LAMZEDE 10 mg, powder for solution for infusion bottle, CIP 3400955051961
Active ingredients: Velmanase alfa
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottle, CIP 3400955051961intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAMZEDE 10 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon en verre de 10 mg ( abrogée le 19/11/2024)
- Marketing authorisation holder
- CHIESI FARMACEUTICI
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Aug 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61080146CIP75505196CIP133400955051961Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VELMANASE ALFApoudre | 10 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.